The effect of erythropoietin on the erythropoiesis
Phase 3
- Conditions
- Anaemia of prematurity.Anaemia of prematurity
- Registration Number
- IRCT201008091380N2
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
premature infants with birth weight<1800g and gestational age<34week that their cardiorespiratory condition were stable. Exclusion criteria: a major congenital malformation, evidence of coagulopathy, severe asphyxia, intraventricular hemorrhage grade 3-4, a positive direct antiglobulin test with clinical symptom of hemolytic anemia, surgical problems, exchange transfusion, severe cardiopulmonary disease required > 40% head box oxygen or dependent on mechanical ventilation, systolic blood pressure > 100mm Hg , an absolute neutrophil counts (ANC) of = 500/µl.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hematocrit. Timepoint: at the beginning and end of study. Method of measurement: with colter counter.
- Secondary Outcome Measures
Name Time Method Pack cell transfusion. Timepoint: at the end of study. Method of measurement: ml.;Ferritin. Timepoint: begining and end of study. Method of measurement: Radioimunoassay.;Reticulocyte. Timepoint: begining and end of study. Method of measurement: Microscope.;Mean daily weight gain. Timepoint: begining and end of study. Method of measurement: Weigher.